REMINDER: Our user survey closes TODAY, please submit your responses here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Https://www.bbc.co.uk/news/uk-wales-66735012
Think this also came up on local SW news. Lack of availability of weight loss drugs for diabetics. Obvious opportunity for Opti. Article even says, drug popular as suppresses appetite. Also, these patients have associated blood pressure problems (PBX).
Here's the spanish website for slimexpert tropical for instance
https://www.hollandandbarrett.es/en/products/holland-barrett-slimexpert-with-slimbiomer-tropical-flavor-21-sachets
stumbled across the above whilst doodling in general this evening - just thought i'd post as on topic
mol
I've also posted further info re the clinical trial info previously posted for sofia and adele's research prior to trial this evening on pbx
mol
Interesting extract from the THG RNS announcing they are to act as fulfilment agents for H&B's growing online business; seems H&B is not such a small concern as some would have you believe.
"Anthony Houghton, Chief Operating Officer, Holland & Barrett, commented:
"Holland & Barrett's goal is to be the trusted health and wellness partner for over 100 million people globally by 2026. We're growing as a business, with digital sales making a significant volume of our total sales. Our proposed three-year partnership with THG Ingenuity will mean we can continue to grow at pace with a partner who are industry experts in D2C fulfilment, while we invest in transforming our supply chain capabilities."
Thanks Aqua for bringing it all together.
Cheers Aquae tick up from me
mol
Most welcome martinu, the adverts are already out there too
https://www.stack3d.com/2024/01/muscletech-nitro-tech-ripped-europe.html
https://twitter.com/Stack3dNews/status/1745091629579489775
https://www.linkedin.com/posts/stack3d_muscletech-is-bringing-its-hyrbid-nitro-tech-activity-7150857426089459712-PB-0
AS, thanks for the reminder. I hadn't made the link.
It’s not sweet though.
No mention of expected revenue in the rns.
Nice to see the Leanbiome launch confirmed, you need to go back to the Commercial update RNS to see its initial value to the company ;
" A large initial order of £116k from a leading weight management and sports nutrition brand in the USA. We anticipate launch in late 2023 or Q1 2024. This is a major sports nutrition brand who are making a significant investment in LeanBiome® as a key differentiator in the protein market and, if successful on launch, will have a material impact on future revenues "
Martin, no wasn’t aware , thanks for that.
Farris, more on this on PBX threads on PBX own BB. (In case you weren't aware).
Director change over at probiotic health, Hansen has left
Optibiotix has been on my radar for a while and bought in recently at what I believe is a good price given the potential news this year.
Looking forward to a good year ahead
Updated analysis at 5 january 2024
https://www.londonstockexchange.com/stock/OPTI/optibiotix-health-plc/analysis
mol
Up
There was no guidance for the second half. Costs have been reduced- at the December meeting O’Hara mentioned that the board had been slimmed, the CEO removed and director salaries cut 20%. The company only employs 10 people of whom half are a shared admin resource with quoted subsidiary Probiotix.
mol
Recent Developments
Last Updated: 13/12/2023
We met founder/CEO Stephen O’Hara on 13 December for a catch up. Optibiotix had released a commercial update on 1 November, building on the July announcement of their Sweetbiotix additive product range, which created a certain amount of interest and was followed by a sharp rise in the share price.
The discussion added emphasis to some of the matters covered in the 1 November release, which gave (unusually for Opti) some numbers including a £116,000 order from a US sports nutrition brand, four new partners for Slimbiome who together are anticipated to provide £150,000 of revenues in 2024. O’Hara reiterated the planned Boots 2024 launch (previously suggested as for Q1), the product listing at Costco, and a US launch of own-brand products in 2024. He also mentioned ongoing discussions for products containing Slimbiome in India in 2024 – this came with forecast sales to Optibiotix of £1.2m in year 1 rising to £6.7m in year 5. The company in November mentioned its e-commerce plans saying that with investment (unquantified) the e-commerce channel “will…become a significant contributor to revenues in 2023 and beyond”- wording was not so emphatic today. He did stress the potential importance of the company’s unnamed US marketing partner, and the potential for DSM/Firmenich to step up production should discussions with companies such as Kellogg, Coca-Cola and Tate and Lyle come to fruition. FMCG manufacturers are very concerned about product stability over potential multi-year shelf lives and he revealed that they had had to reformulate to stop their product sedimenting out of a liquid (presumably Coca-Cola…).
Perhaps more importantly, O’Hara seems to have realised that the AIM market wants to see delivery and profitability, and said that he sees all the main pillars of the business becoming profitable over the next year and the whole company becoming profitable not so far behind. He insisted that there was no point making any sort of detailed guidance since he could not rely on his customers to provide meaningful forecasts of sales themselves – which is not unreasonable. However, until some of them start delivering meaningful numbers it will be hard to assess success.
In late October the company announced a licence agreement with Tata Chemicals to incorporate Tata’s Fossence into Slimbiome and LeanBiome for the Indian market, replacing an ingredient used elsewhere. Fossence is an established branded ingredient in India, so this will presumably help with marketing.
Half year results released on 27 September showed a 195% increase in sales YoY, but still only to £351,000. Admin expenses were cut by 17.3% and the company managed a gross profit of £158,000. Overall loss at the pretax level was £1.854m, which came out as 2.09p/ share. Cash stood at £893,000 so a further sell down of shares in one or both of the quoted subsidiaries seems likely. There was no gu
Further to other post. Overwhelming impression was that nearly the whole shop was aimed at gut health. With SlimExpert (SlimBiome) a small, difficult to find display. ** But the very helpful assistant said lots more slimming products online. I asked her what she knew about SlimBiome and she said they'd been given training on it about 3 years ago. She also said a lot of customers didn't really ask if products were backed by scientific trials. I told her about WellBiome and LeanBiome which were not in store. Also told her about Cholbiome, which I didn't expect to see. And indeed, SweetBiome. She was extremely polite and thanked me for extending her education. Poor girl!!
** In same display were competitors BoomBod and XLS (?). And someone else's gummies too.
Just been in Marks in Plymurf. Big sign advertising the Zoe gut shot. So, decided to go in H&B. SlimBiome hidden at back of store, but did have a small display card explaining the clinical backing. More to follow on H&B experience.
Cheers Aquae
Hadn’t thought of Australia - was hoping for US
mol
There you go mol
https://www.costco.com.au/search?searchOption=au-search-all&text=optislim
Just noticed blog subjects on right hand side
obviously a WIP as any i've clicked go back to 2019!
jees just wish Shiraz and designer could get it right before going live
mol
Nothing as yet from a search for slimbiome but perhaps we need to know the partner and product though if slimbiome incorporated i would think a search should reveal as it is a registered tradmark
https://www.costco.com/CatalogSearch?dept=All&keyword=slimbiome
mol